Bank Of New York Mellon Corp T2 Biosystems, Inc. Transaction History

Bank Of New York Mellon Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.09 - $565.0 $39,647 - $249 Million	440,531 Added 449.48%	538,540 $61,000
Q1 2021 May 13, 2021	SELL	$1.32 - $3.79 $13,585 - $39,006	-10,292 Reduced 9.5%	98,009 $158,000
Q4 2020 Feb 09, 2021	BUY	$1.06 - $1.51 $69,806 - $99,441	65,855 Added 155.15%	108,301 $134,000
Q2 2020 Aug 12, 2020	BUY	$0.48 - $1.67 $5,423 - $18,869	11,299 Added 36.28%	42,446 $53,000
Q4 2019 Feb 14, 2020	BUY	$0.96 - $2.94 $915 - $2,804	954 Added 3.16%	31,147 $36,000
Q2 2019 Aug 12, 2019	SELL	$1.47 - $3.16 $103,530 - $222,555	-70,429 Reduced 69.99%	30,193 $51,000
Q1 2019 May 14, 2019	SELL	$2.56 - $4.48 $7,577 - $13,260	-2,960 Reduced 2.86%	100,622 $264,000
Q4 2018 Feb 11, 2019	BUY	$2.98 - $6.86 $70,512 - $162,321	23,662 Added 29.61%	103,582 $312,000
Q3 2018 Nov 09, 2018	BUY	$5.36 - $7.83 $42,799 - $62,522	7,985 Added 11.1%	79,920 $0
Q2 2018 Aug 06, 2018	BUY	$5.97 - $9.58 $278,004 - $446,111	46,567 Added 183.57%	71,935 $556,000
Q1 2018 May 15, 2018	BUY	$4.21 - $7.0 $61,663 - $102,529	14,647 Added 136.62%	25,368 $164,000
Q4 2017 Feb 09, 2018	BUY	$3.73 - $4.6 $39,989 - $49,316	10,721	10,721 $44,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.88M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.